AKT1 and breast cancer: Consistently, the administration of perifosine (an inhibitor of AKT) or Ly294002 (an inhibitor of PI3 K), either alone or in conjunction with chemotherapy, decreases the population of mammary stem cells and inhibits the formation of tumors in BC xenografts (Korkaya et al. 2009; Wylaz et al. 2023).